Monitoring colon cancer with blood tests after surgery
Part of Brain & nervous system, Cancer, Digestive system, Genetic & congenital clinical trials.
This study is testing a new way to monitor colon cancer after surgery by looking for cancer DNA in your blood. It may help doctors detect if cancer comes back earlier and guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with stage I, II, or III colon cancer (adenocarcinoma).
- You have not received any cancer treatment (surgery, chemotherapy, radiation, or targeted therapy) for this cancer yet.
- You are in good overall health (able to carry out daily activities with little or no help).
- Your tumor has a change in at least one of these genes: KRAS, NRAS, BRAF, or PIK3CA.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at ways to better predict how early-stage colon cancer will respond to standard treatment. It is focused on patients who will have surgery to remove the tumor and have not yet had any other cancer treatment.
This study checks a special blood test (circulating tumor DNA methylation) to help guide follow-up after surgery for non-metastatic colon cancer. It may help find whether additional treatment or closer monitoring is needed based on the test results.
This study tests if a simple blood test can detect early signs of colorectal cancer coming back after surgery to remove cancer spread in the abdomen. It may help patients avoid unnecessary treatments and catch recurrence sooner.
This study uses a simple blood test to detect cancer DNA after surgery for early-stage colon cancer. The goal is to help doctors decide whether chemotherapy is truly needed based on the blood test results, rather than giving it to everyone.
This study helps doctors decide whether you need chemotherapy after colon cancer surgery by checking for cancer DNA in your blood. The goal is to give chemotherapy only to patients who truly need it, based on what the blood test shows.
This trial checks a blood test for “ctDNA methylation” to see who may be at higher risk of colorectal cancer returning after surgery. It may help doctors better judge whether adjuvant chemotherapy is working or needed.
Hear when a new Colon Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.